UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
Quarterly Report
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
For the quarterly period ended September 30, 2004
Commission file number 1-496
HERCULES INCORPORATED
A Delaware corporation
I.R.S. Employer Identification No. 51-0023450
Hercules Plaza
1313 North Market Street
Wilmington, Delaware 19894-0001
Telephone: 302-594-5000
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes: X No: _
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Securities Exchange Act).
Yes: X No: _
As of October 29, 2004, 111,965,968 shares of registrant's common stock were outstanding.
Hercules Incorporated
TABLE OF CONTENTS
|
Part I - Financial Information.......................................................................................................................... |
3 |
|
Item 1. Consolidated Financial Statements.............................................................................................. |
3 |
|
Consolidated Statements of Operations............................................................................................... |
3 |
|
Consolidated Balance Sheets................................................................................................................. |
4 |
|
Consolidated Statements of Cash Flows.............................................................................................. |
5 |
|
Consolidated Statements of Comprehensive (Loss) Income............................................................. |
6 |
|
Notes to Consolidated Financial Statements....................................................................................... |
7 |
|
Item 2. Management's Discussion and Analysis of Financial Condition and Results of |
|
|
Overview.................................................................................................................................................... |
35 |
|
Critical Accounting Estimates................................................................................................................ |
37 |
|
Results of Operations.............................................................................................................................. |
40 |
|
Financial Condition.................................................................................................................................. |
46 |
|
Risk Factors............................................................................................................................................... |
47 |
|
Indemnifications....................................................................................................................................... |
49 |
|
Recent Accounting Pronouncements................................................................................................... |
49 |
|
Forward-Looking Statements................................................................................................................. |
50 |
|
Item 3. Quantitative and Qualitative Disclosures About Market Risk................................................ |
50 |
|
Item 4. Controls and Procedures............................................................................................................... |
50 |
|
Part II - Other Information............................................................................................................................... |
52 |
|
Item 1. Legal Proceedings.......................................................................................................................... |
52 |
|
Item 6. Exhibits............................................................................................................................................. |
52 |
|
Signature........................................................................................................................................................ |
53 |
|
Exhibit Index.................................................................................................................................................. |
54 |
|
|
||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||
|
HERCULES INCORPORATED |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
|
||||||||||||||||||||||||||||||
|
|
(Unaudited) |
(Unaudited) |
|
|||||||||||||||||||||||||||
|
(Dollars in millions, expect per share) |
Three Months Ended |
Nine Months Ended |
|
|||||||||||||||||||||||||||
|
September 30, |
September 30, |
|
||||||||||||||||||||||||||||
|
2004 |
2003 |
2004 |
2003 |
|
||||||||||||||||||||||||||
|
Net sales |
$ |
501 |
$ |
463 |
$ |
1,486 |
$ |
1,388 |
|
|||||||||||||||||||||
|
Cost of sales (Note 6) |
328 |
289 |
958 |
|
871 |
|
||||||||||||||||||||||||
|
Selling, general and administrative expenses (Note 6) |
94 |
89 |
290 |
270 |
|
|||||||||||||||||||||||||
|
Research and development |
11 |
9 |
33 |
29 |
|
|||||||||||||||||||||||||
|
Intangible asset amortization (Note 4) |
2 |
2 |
6 |
6 |
|
|||||||||||||||||||||||||
|
Other operating expense, net (Note 7) |
1 |
9 |
23 |
10 |
|
|||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||
|
Profit from operations |
65 |
65 |
176 |
202 |
|
|||||||||||||||||||||||||
|
Interest and debt expense |
25 |
32 |
85 |
99 |
|
|||||||||||||||||||||||||
|
Other expense, net (Note 8) |
50 |
7 |
68 |
17 |
|
|||||||||||||||||||||||||
|
(Loss) income before income taxes and equity income |
(10) |
26 |
23 |
86 |
||||||||||||||||||||||||||
|
Provision for income taxes (Note 17) |
41 |
9 |
44 |
23 |
||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||
|
(Loss) income before equity income |
(51) |
17 |
(21) |
63 |
|
|||||||||||||||||||||||||
|
Equity income of affiliated companies, net of tax |
- |
- |
- |
- |
|
|||||||||||||||||||||||||
|
Net (loss) income from continuing operations before discontinued operations and cumulative effect of changes |
|
|||||||||||||||||||||||||||||
|
in accounting principle |
(51) |
17 |
(21) |
63 |
|
|||||||||||||||||||||||||
|
Net income on discontinued operations, net of tax |
- |
- |
- |
2 |
|
|||||||||||||||||||||||||
|
Net (loss) income before cumulative effect of changes in |
|
|||||||||||||||||||||||||||||
|
accounting principle |
(51) |
17 |
(21) |
65 |
|
|||||||||||||||||||||||||
|
Cumulative effect of changes in accounting principle, |
|
|||||||||||||||||||||||||||||
|
net of tax |
- |
- |
- |
(28) |
|
|||||||||||||||||||||||||
|
Net (loss) income |
$ |
(51) |
$ |
17 |
$ |
(21) |
$ |
37 |
|
|||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||
|
Basic (loss) earnings per share (Note 5) |
|
|||||||||||||||||||||||||||||
|
Continuing operations |
$ |
(0.47) |
$ |
0.16 |
$ |
(0.20) |
$ |
0.59 |
|
|||||||||||||||||||||
|
Discontinued operations |
- |
- |
- |
0.02 |
|
|||||||||||||||||||||||||
|
Cumulative effect of changes in accounting principle |
- |
- |
- |
(0.26) |
|
|||||||||||||||||||||||||
|
Net (loss) income |
$ |
(0.47) |
$ |
0.16 |
$ |
(0.20) |
$ |
0.35 |
|
|||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||
|
Diluted (loss) earnings per share (Note 5) |
|
|||||||||||||||||||||||||||||
|
Continuing operations |
$ |
(0.47) |
$ |
0.16 |
$ |
(0.20) |
$ |
0.58 |
|
|||||||||||||||||||||
|
Discontinued operations |
- |
- |
- |
0.02 |
|
|||||||||||||||||||||||||
|
Cumulative effect of changes in accounting principle |
- |
- |
- |
(0.26) |
|
|||||||||||||||||||||||||
|
Net (loss) income |
$ |
(0.47) |
$ |
0.16 |
$ |
(0.20) |
$ |
0.34 |
|
|||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||
|
Weighted-average number of shares - diluted (millions) |
107.7 |
107.6 |
107.2 |
107.9 |
|
|||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||
|
See accompanying notes to consolidated financial statements. |
|
|||||||||||||||||||||||||||||
|
HERCULES INCORPORATED |
|||||||
|
(Dollars in millions) |
|
(Unaudited) |
|
|
|
(Unaudited) |
|
|
|
|
September 30, |
December 31, |
||||
|
2004 |
2003 |
||||||
|
As Restated |
|||||||
|
ASSETS |
|
|
|
|
|
|
|
|
Current assets |
|||||||
|
Cash and cash equivalents |
$ |
99 |
$ |
125 |
|||
|
Accounts and notes receivable (net of allowance for doubtful |
|||||||
|
accounts of $8 million and $5 million, respectively) |
401 |
408 |
|||||
|
Inventories |
|||||||
|
Finished products |
99 |
100 |
|||||
|
Raw materials, work-in-process and supplies |
94 |
87 |
|||||
|
Deferred income taxes |
104 |
93 |
|||||
|
Asbestos-related assets (Note 14) |
16 |
7 |
|||||
|
Total current assets |
813 |
820 |
|||||
|
Property, plant, and equipment |
2,029 |
2,039 |
|||||
|
Accumulated depreciation and amortization |
(1,361 |
) |
(1,362 |
) |
|||
|
Net property, plant, and equipment |
668 |
677 |
|||||
|
Intangible assets, net (Note 4) |
164 |
165 |
|||||
|
Goodwill, net (Note 4) |
523 |
518 |
|||||
|
Deferred income taxes |
94 |
44 |
|||||
|
Asbestos-related assets (Note 14) |
172 |
162 |
|||||
|
Other assets |
224 |
325 |
|||||
|
Total assets |
$ |
2,658 |
$ |
2,711 |
|||
|
LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY |
|||||||
|
Current liabilities |
|||||||
|
Accounts payable |
$ |
193 |
$ |
192 |
|||
|
Accrued expenses |
187 |
198 |
|||||
|
Asbestos-related liabilities (Note 14) |
47 |
45 |
|||||
|
Current maturities of long-term debt (Note 10) |
24 |
22 |
|||||
|
Total current liabilities |
451 |
457 |
|||||
|
Long-term debt (Note 10) |
1,269 |
1,326 |
|||||
|
Deferred income taxes |
80 |
78 |
|||||
|
Pension liability (Note 12) |
280 |
249 |
|||||
|
Other postretirement benefits (Note 12) |
85 |
96 |
|||||
|
Deferred credits and other liabilities |
315 |
318 |
|||||
|
Asbestos-related liabilities (Note 14) |
218 |
176 |
|||||
|
Commitments and contingencies (Note 14) |
- |
- |
|||||
|
Stockholders' (deficit) equity |
|||||||
|
Series preferred stock |
- |
- |
|||||
|
Common stock, (shares issued and outstanding: |
|||||||
|
2004 – 159,984,444; 2003 - 159,984,444) |
83 |
83 |
|||||
|
Additional paid-in capital |
573 |
603 |
|||||
|
Unearned compensation |
(80 |
) |
(87 |
) |
|||
|
Accumulated other comprehensive losses |
(359 |
) |
(317 |
) |
|||
|
Retained earnings |
1,474 |
1,495 |
|||||
|
1,691 |
1,777 |
||||||
|
Reacquired stock, at cost (shares: 2004 – 48,052,728; |
|||||||
|
2003 - 48,992,628) |
1,731 |
1,766 |
|||||
|
Total stockholders' (deficit) equity |
(40 |
) |
11 |
||||
|
Total liabilities and stockholders' (deficit) equity |
$ |
2,658 |
$ |
2,711 |
|||
|
See accompanying notes to consolidated financial statements. |
|||||||
|
HERCULES INCORPORATED |
|
|
||||||
|
|
|
|||||||
|
(Dollars in millions) |
(Unaudited) |
|||||||
|
|
Nine Months Ended |
|||||||
|
2004 |
2003 |
|||||||
|
Cash Flows from Operating Activities: |
|
|
|
|
||||
|
Net (loss) income |
$ |
(21 |
) |
$ |
37 |
|||
|
Adjustments to reconcile net (loss) income to net cash provided by |
||||||||
|
Depreciation |
56 |
53 |
||||||
|
Amortization |
20 |
20 |
||||||
|
Deferred income tax benefit |
(9 |
) |
(12 |
) |
||||
|
Nonoperating gain on disposals |
(26 |
) |
(1 |
) |
||||
|
Impairment charges |
7 |
- |
||||||
|
&nb | ||||||||